» Articles » PMID: 29459031

Subcellular Targeting of Nitric Oxide Synthases Mediated by Their N-Terminal Motifs

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2018 Feb 21
PMID 29459031
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

From a catalytic point of view, the three mammalian nitric oxide synthases (NOSs) function in an almost identical way. The N-terminal oxygenase domain catalyzes the conversion of l-arginine to l-citrulline plus ·NO in two sequential oxidation steps. Once l-arginine binds to the active site positioned above the heme moiety, two consecutive monooxygenation reactions take place. In the first step, l-arginine is hydroxylated to make Nω-hydroxy-l-arginine in a process that requires 1 molecule of NADPH and 1 molecule of O per mol of l-arginine reacted. In the second step, Nω-hydroxy-l-arginine, never leaving the active site, is oxidized to ·NO plus l-citrulline and 1 molecule of O and 0.5 molecules of NADPH are consumed. Since nitric oxide is an important signaling molecule that participates in a number of biological processes, including neurotransmission, vasodilation, and immune response, synthesis and release of ·NO in vivo must be exquisitely regulated both in time and in space. Hence, NOSs have evolved introducing in their amino acid sequences subcellular targeting motifs, most of them located at their N-termini. Deletion studies performed on recombinant, purified NOSs have revealed that part of the N-terminus of all three NOS can be eliminated with the resulting mutant enzymes still being catalytically active. Likewise, NOS isoforms lacking part of their N-terminus when transfected in cells render mislocalized, active proteins. In this review we will comment on the current knowledge of these subcellular targeting signals present in nNOS, iNOS, and eNOS.

Citing Articles

Jiaohong pills attenuate neuroinflammation and amyloid-β protein-induced cognitive deficits by modulating the mitogen-activated protein kinase/nuclear factor kappa-B pathway.

Zhang H, Cai W, Dong L, Yang Q, Li Q, Ran Q Animal Model Exp Med. 2024; 7(3):222-233.

PMID: 38177948 PMC: 11228096. DOI: 10.1002/ame2.12369.


Tripterygium glycoside ameliorates neuroinflammation in a mouse model of Aβ25-35-induced Alzheimer's disease by inhibiting the phosphorylation of IκBα and p38.

Tang L, Xiang Q, Xiang J, Zhang Y, Li J Bioengineered. 2021; 12(1):8540-8554.

PMID: 34592905 PMC: 8806986. DOI: 10.1080/21655979.2021.1987082.


The diversification and lineage-specific expansion of nitric oxide signaling in Placozoa: insights in the evolution of gaseous transmission.

Moroz L, Romanova D, Nikitin M, Sohn D, Kohn A, Neveu E Sci Rep. 2020; 10(1):13020.

PMID: 32747709 PMC: 7400543. DOI: 10.1038/s41598-020-69851-w.


Nitric oxide in cellular adaptation and disease.

Gantner B, LaFond K, Bonini M Redox Biol. 2020; 34:101550.

PMID: 32438317 PMC: 7235643. DOI: 10.1016/j.redox.2020.101550.